Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy
Clinical trial NCT00063570 · COMPLETED
Trial details
- NCT number
- NCT00063570
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-07-01
- Primary completion
- 2008-01-01
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.